View Older Stories View More Recent Stories

Sep 30, 2026 07:40AM Lake Street Starts Rezolute (RZLT) at Buy
Sep 29, 2026 09:41AM Craig-Hallum Upgrades Rezolute (RZLT) to Buy
Sep 28, 2026 07:00AM Rezolute (RZLT) PT Raised to $10 at H.C. Wainwright
Sep 25, 2026 12:54PM Rezolute (RZLT) PT Raised to $10 at H.C. Wainwright
Sep 25, 2026 04:16AM Rezolute (RZLT) Reiterated at Market Outperform by Citizens After Q4 Results
Jul 30, 2026 06:53AM H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
Jun 17, 2026 07:03AM Rezolute presents hyperinsulinism data at Endocrine Society meeting
Jun 15, 2026 06:53AM Rezolute (RZLT) PT Raised to $11 at Guggenheim
Jun 3, 2026 06:50AM Rezolute (RZLT) Reiterated at Neutral by Cantor Fitzgerald
Jun 2, 2026 04:53PM Citizens Upgrades Rezolute (RZLT) to Market Outperform
Jun 2, 2026 03:16PM Rezolute (RZLT) PT Raised to $6 at Wedbush
May 13, 2026 07:53AM H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
May 12, 2026 05:33PM Rezolute, Inc. (RZLT) Tops Q3 EPS by 2c
May 4, 2026 07:29AM H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
Mar 25, 2026 07:02AM Rezolute (RZLT) Reiterated at Neutral by Cantor Fitzgerald After FDA Meeting
Mar 25, 2026 06:58AM H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
Mar 25, 2026 06:37AM Wedbush Upgrades Rezolute (RZLT) to Outperform
Mar 25, 2026 05:33AM Rezolute (RZLT) Reiterated at Market Perform by Citizens on CHI Program Clarity
Mar 24, 2026 03:40PM BTIG sees 'incremental positives' in Rezolute (RZLT) regulatory update
Feb 12, 2026 04:40PM Rezolute, Inc. (RZLT) Misses Q2 EPS by 3c
Jan 26, 2026 05:33AM Rezolute Inc. (RZLT) February 5 calls active
Jan 8, 2026 04:13AM Jefferies Reiterates Buy Rating on Rezolute (RZLT)
Dec 12, 2025 03:00PM RZLT INVESTIGATION: Rezolute, Inc. Investors Should Contact Block & Leviton LLP To Potentially Recover Losses
Dec 12, 2025 09:19AM Craig-Hallum Downgrades Rezolute (RZLT) to Hold
Dec 12, 2025 07:12AM Rezolute (RZLT) PT Lowered to $6 at Guggenheim
Dec 12, 2025 06:43AM Rezolute (RZLT) PT Lowered to $5 at H.C. Wainwright
Dec 11, 2025 12:27PM Rezolute (RZLT) PT Lowered to $5 at BTIG
Dec 11, 2025 11:37AM Cantor Fitzgerald Downgrades Rezolute (RZLT) to Neutral
Dec 11, 2025 10:22AM Wedbush Downgrades Rezolute (RZLT) to Neutral
Nov 12, 2025 07:32AM Rezolute (RZLT) PT Raised to $14 at Jones Trading
Nov 6, 2025 06:24PM Rezolute, Inc. (RZLT) Tops Q1 EPS by 4c
Nov 6, 2025 06:24PM Rezolute, Inc. (RZLT) Tops Q1 EPS by 4c
Oct 29, 2025 04:26AM Rezolute (RZLT) PT Raised to $17 at Citizens After Phase 3 sunRIZE Results
Sep 18, 2025 05:27AM Rezolute (RZLT) PT Raised to $14 at Jefferies
Sep 18, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Rezolute (RZLT)
Sep 3, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
Aug 20, 2025 06:14AM Rezolute Inc. (RZLT) Appoints Sunil Karnawat as Chief Commercial Officer
Jul 24, 2025 08:49AM Cantor Fitzgerald Reiterates Overweight Rating on Rezolute (RZLT)
Jul 17, 2025 05:06PM Rezolute Inc. (RZLT) Files for 1.3M Share Offering by Selling Stockholders
May 28, 2025 02:27PM BTIG Reiterates Buy Rating on Rezolute (rzlt)
May 28, 2025 08:02AM Rezolute Inc. (RZLT) Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
May 14, 2025 04:55PM Rezolute, Inc. (RZLT) Misses Q3 EPS by 3c
May 5, 2025 08:02AM Rezolute (RZLT) Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
Apr 23, 2025 08:05AM Rezolute Inc. (RZLT) Announces $90M Share and Warrant Offering at $3.25/sh
Apr 23, 2025 08:04AM Rezolute (RZLT) Announces Positive Recommendation After Independent Interim Analysis of Phase 3 sunRIZE Study of Ersodetug in Congenital Hyperinsulinism
Mar 26, 2025 07:31AM Rezolute Inc. (RZLT) Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors
Feb 13, 2025 04:14AM Rezolute (RZLT) PT Raised to $9 at JMP Securities
Feb 12, 2025 05:43PM Rezolute, Inc. (RZLT) Tops Q2 EPS by 3c
Feb 5, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
Feb 4, 2025 08:00AM Rezolute Inc. (RZLT) Provides Update on its Phase 3 sunRIZE Study of Ersodetug
View More Recent Stories View Older Stories